In 2023, the tuberculosis mortality rate in the US was anticipated to remain stable without specific values provided. The forecast for 2024 to 2028 indicates a constant mortality rate of 200 deaths per hundred people each year. This stability showcases a lack of year-on-year variation, suggesting a plateau in the mortality rate over this period. As there are no changes in the annual figures, the Compound Annual Growth Rate (CAGR) remains at 0% for the forecasted horizon.

Future trends to watch for include:

Potential breakthroughs in tuberculosis treatment or prevention that could reduce mortality rates.
The impact of healthcare policies and funding on tuberculosis management.
Possible emerging resistance to current treatments that may affect mortality rates.